ABBOTT LABORATORIES (ABT) Net income 2016–2025
ABBOTT LABORATORIES (ABT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$6.5BFY2025 · since FY2016: $1.4B → $6.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.5B | -51.3% |
| FY2024 | $13.4B | +134.2% |
| FY2023 | $5.7B | -17.5% |
| FY2022 | $6.9B | -2.0% |
| FY2021 | $7.1B | +57.3% |
| FY2020 | $4.5B | +21.9% |
| FY2019 | $3.7B | +55.7% |
| FY2018 | $2.4B | +396.4% |
| FY2017 | $477.0M | -65.9% |
| FY2016 | $1.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice